Americans most directly affected by this bill would be individuals who have been significantly exposed to PFAS chemicals, particularly those who live or have lived near manufacturing facilities or areas where these chemicals were released. These individuals could gain a new legal pathway to seek compensation for medical monitoring, potentially alleviating the financial burden of health screenings related to PFAS exposure.

Manufacturers and companies involved in creating or using PFAS chemicals would also be significantly affected. They could face increased legal challenges and be held financially responsible for the medical monitoring of individuals exposed to the PFAS they produced or released. This could lead to changes in manufacturing practices, increased investment in safety research, and potentially higher costs for these industries.